Page last updated: 2024-10-29

ifosfamide and B-Cell Leukemia

ifosfamide has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffin, TC1
Weitzman, S1
Weinstein, H1
Chang, M1
Cairo, M1
Hutchison, R1
Shiramizu, B1
Wiley, J1
Woods, D1
Barnich, M1
Gross, TG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia[NCT01429610]Phase 278 participants (Actual)Interventional2011-11-30Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ifosfamide and B-Cell Leukemia

ArticleYear
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:2

    Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined

2009